Is nasolacrimal duct obstruction (NLDO) common bilaterally?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Bilateral Nasolacrimal Duct Obstruction Prevalence

Bilateral nasolacrimal duct obstruction (NLDO) is less common than unilateral NLDO, occurring in approximately 40% of all NLDO cases, while unilateral cases account for about 60% of presentations.

Epidemiology and Prevalence

  • Congenital nasolacrimal duct obstruction is one of the most frequently observed congenital abnormalities of the nose, with an overall incidence of 1 in 7000-8000 live births 1
  • The ratio of bilateral to unilateral NLDO is approximately 40% to 60%, making bilateral cases less common than unilateral presentations 1
  • Symptomatic NLDO occurs in approximately 5-6% of infants overall 2
  • In studies examining treatment approaches, bilateral NLDO represented a smaller proportion of cases compared to unilateral obstruction 3

Clinical Characteristics of Bilateral NLDO

  • Bilateral NLDO may be associated with other congenital abnormalities in up to 50% of cases, with this percentage increasing to 75% in bilateral manifestations 1
  • The CHARGE syndrome (Coloboma, Heart defects, Atresia of the choanae, Retardation, Genital and Ear abnormalities) is the most frequent syndromal association, occurring in about 20% of cases 1
  • Other associated malformations include meningoceles, hypertelorism, and clefts 1

Treatment Considerations for Bilateral NLDO

  • Treatment success rates may differ between bilateral and unilateral cases:
    • In one study, children with bilateral NLDO had a 76% success rate with observation and deferred facility probing compared to 66% success with immediate office probing 3
    • This differs from unilateral cases, where immediate probing showed better success rates 4

Anatomical Considerations

  • Patients with bilateral NLDO have been found to have a significantly higher rate of concomitant nasal pathologies requiring surgical intervention (78.6%) compared to unilateral NLDO patients (26.7%) 5
  • These nasal abnormalities include septal deviation, concha bullosa, and inferior turbinate hypertrophy, which may contribute to the bilateral obstruction 5
  • Septoplasty was required in 57.1% of bilateral NLDO cases versus only 16.7% in unilateral cases 5

Management Implications

  • The higher prevalence of associated nasal abnormalities in bilateral NLDO suggests that comprehensive nasal evaluation is particularly important in these cases 5
  • Treatment approaches may need to address both the nasolacrimal duct obstruction and any concomitant nasal pathology 5
  • Spontaneous resolution can occur in bilateral cases, with one study showing resolution without surgery in both eyes for 56% of participants within 6 months of observation 3

Prognosis

  • Late probing (after 15 months of age) for congenital NLDO showed a success rate of 83% in bilateral cases compared to 72% in unilateral cases 6
  • The presence of bilateral disease may indicate more extensive anatomical issues that could affect long-term outcomes 5

In summary, while bilateral NLDO is less common than unilateral presentation, it is associated with a higher likelihood of concomitant nasal abnormalities and may be linked to syndromic conditions. This suggests that bilateral NLDO might represent a more complex anatomical or developmental issue rather than an isolated finding.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Probing for congenital nasolacrimal duct obstruction.

The Cochrane database of systematic reviews, 2017

Research

Late probing for congenital nasolacrimal duct obstruction.

Journal of ophthalmic & vision research, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.